KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Non-Current Deferred Tax Liability: 2020-2024

Historic Non-Current Deferred Tax Liability for Castle Biosciences (CSTL) over the last 5 years, with Dec 2024 value amounting to $1.6 million.

  • Castle Biosciences' Non-Current Deferred Tax Liability fell 23.18% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 23.18%. This contributed to the annual value of $1.6 million for FY2024, which is 93.49% down from last year.
  • As of FY2024, Castle Biosciences' Non-Current Deferred Tax Liability stood at $1.6 million, which was down 93.49% from $24.7 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Non-Current Deferred Tax Liability registered a high of $27.1 million during FY2022, and its lowest value of $1.6 million during FY2024.
  • In the last 3 years, Castle Biosciences' Non-Current Deferred Tax Liability had a median value of $24.7 million in 2023 and averaged $17.8 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first soared by 410.99% in 2021, then crashed by 93.49% in 2024.
  • Yearly analysis of 5 years shows Castle Biosciences' Non-Current Deferred Tax Liability stood at $3.8 million in 2020, then skyrocketed by 410.99% to $19.6 million in 2021, then soared by 38.56% to $27.1 million in 2022, then decreased by 9.00% to $24.7 million in 2023, then crashed by 93.49% to $1.6 million in 2024.